Print

Conatus Pharmaceuticals Inc. Announces Second Quarter 2013 Financial Results  
9/10/2013 9:15:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter ended June 30, 2013.

Help employers find you! Check out all the jobs and post your resume.

//-->